Screening for breast cancer

Stephen W. Duffy, Robert A. Smith, Rhian Gabe, László Tabár, Amy M F Yen, Tony H H Chen

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Strong evidence supports the value of breast cancer screening with mammography, and high-quality mammography screening can be considered a major public health achievement [99]. As noted earlier in the discussion about the evaluation of service screening, the group of women who did not participate in mammographic screening in the decades after screening had been introduced had essentially unchanged or only minor improvements in mortality compared with the pattern before the introduction of screening, despite widespread use of adjuvant chemotherapy or hormonal therapy [100]. Breast cancer should be treated in its preclinical phase if we are to save the lives of women with this disease, and a considerable body of evidence outlines best practices that, with broader adherence, would result in greater breast cancer mortality reductions than have been observed to date.

Original languageEnglish
Pages (from-to)671-697
Number of pages27
JournalSurgical Oncology Clinics of North America
Volume14
Issue number4
DOIs
Publication statusPublished - Oct 2005
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Surgery

Fingerprint Dive into the research topics of 'Screening for breast cancer'. Together they form a unique fingerprint.

  • Cite this

    Duffy, S. W., Smith, R. A., Gabe, R., Tabár, L., Yen, A. M. F., & Chen, T. H. H. (2005). Screening for breast cancer. Surgical Oncology Clinics of North America, 14(4), 671-697. https://doi.org/10.1016/j.soc.2005.06.001